| Sep 10 |
PainReform to raise $1.58M through exercise of warrants
|
| Sep 10 |
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
|
| Sep 9 |
Upcoming Stock Splits This Week (September 9 to September 13) – Stay Invested
|
| Aug 21 |
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures
|
| Aug 20 |
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
|
| Aug 16 |
PainReform reports 1H results
|
| Aug 15 |
PainReform Provides Business Update for the Second Quarter of 2024
|
| Aug 12 |
PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects
|
| Aug 7 |
PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses
|
| Aug 5 |
PainReform Ltd. Announces Favorable Wound Healing Data in Human Clinical Trials for PRF-110
|
